Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
about
Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in ratsProtective Effect of Safranal, a Constituent of Crocus sativus, on Quinolinic Acid-induced Oxidative Damage in Rat Hippocampus.Reactive oxygen species induce neurite degeneration before induction of cell death.Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.Studying neurodegenerative diseases in culture models.Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity.Huntington's Disease: Calcium Dyshomeostasis and Pathology ModelsNeurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.Probucol Protects Against Asymmetric Dimethylarginine-Induced Apoptosis in the Cultured Human Brain Microvascular Endothelial Cells.Supercritical fluid chromatography with tandem mass spectrometry combined with postcolumn compensation and one-step acetone protein precipitation to evaluate the bioavailability of probucol solid dispersion tablet.The N-Methyl-d-Aspartate Receptor Antagonist MK-801 Prevents Thallium-Induced Behavioral and Biochemical Alterations in the Rat Brain.Probucol attenuates ethanol-induced liver fibrosis in rats by inhibiting oxidative stress, extracellular matrix protein accumulation and cytokine production.Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
P2860
Q28533959-066AC663-35A7-4782-B09D-B56C0EC76289Q36799653-0FE3CBCF-0B91-4AEE-8768-28DDB8DD2EADQ37416568-1339905E-D87C-4400-92C0-623AB3BACDB5Q37607467-3D32B4AD-9C71-4912-B023-9BB47307F2E5Q38165760-168FE8C0-500F-4F7B-8BCA-BEED7D3CEE05Q38916576-27AEDD96-7078-463E-9C69-3C2D315D1399Q39456024-40571187-4EB2-4E0E-AA2E-20BF64CE6274Q42108641-188B6E76-948C-4592-BC3E-2BC39CE92FD9Q43184352-12624294-7BCF-447F-AB3E-4D954088D89AQ44047703-98DB37FA-0CD9-479E-8D6D-14FF75695508Q46687193-F6EC4D2C-219A-47C0-AA5A-0767E6186477Q51600809-83FFF9C0-F349-4819-89BE-BFC2722C46DBQ52149719-8B6E1F13-C5C7-4A80-BE7A-BEA1FFE30E8EQ54239987-4FC5170E-3E3F-441A-B624-94F0EF1A136DQ58780496-A35F8B9D-49A4-4DFF-B3EA-AE9F728DB04D
P2860
Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Probucol modulates oxidative s ...... ton's disease models in vitro.
@en
Probucol modulates oxidative s ...... ton's disease models in vitro.
@nl
type
label
Probucol modulates oxidative s ...... ton's disease models in vitro.
@en
Probucol modulates oxidative s ...... ton's disease models in vitro.
@nl
prefLabel
Probucol modulates oxidative s ...... ton's disease models in vitro.
@en
Probucol modulates oxidative s ...... ton's disease models in vitro.
@nl
P50
P1476
Probucol modulates oxidative s ...... gton's disease models in vitro
@en
P2093
Juliana M Hartwig
P304
P356
10.1016/J.BRAINRESBULL.2012.01.003
P577
2012-01-11T00:00:00Z